New test allows breast cancer patients to safely skip chemo

Professor Janice Walshe said: "We had a 58% reduction in chemotherapy administration, and when we included the price of the test there was about €3m saved."

A breast cancer patient who availed of a new test allowing her to safely skip chemotherapy has hailed the new technology, saying it gave her time and better quality of life.  

Geraldine, age 62 now and living in the southeast, is one of 480 women in Ireland who avoided chemotherapy after genetic testing identified they could safely rely on other treatment instead. New analysis of the test's impact over 10 years also suggests they saved the HSE €3m.